Brief: Eledon Pharmaceuticals Q3 basic EPS USD -0.35
09/11/2023 22:19
Nov 9 (Reuters) - Eledon Pharmaceuticals Q3 net income USD -10.349 million. * Q3 basic EPS USD -0.35 * Q3 operating expenses USD 11.198 million * Q3 income from operations USD -11.198 million
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial